SAB Biotherapeutics (SABS) Misses Q2 EPS by 79c
Tweet
Share
E-mailGet Alerts SABS Hot Sheet
Join SI Premium – FREE
SAB Biotherapeutics (NASDAQ: SABS) reported Q2 EPS of ($0.79).
For earnings history and earnings-related data on SAB Biotherapeutics (SABS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Cosmos Health antiseptic product nears $1.3M in annualized sales in Greece
- ICON plc (ICLR) PT Raised to $170 at Leerink
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
